Glassman Wealth Services Regeneron Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $2,325 - $2,645	3 Added 2.36%	130 $114,000
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 0.78%	127 $104,000
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $2,800 - $3,321	4 Added 3.23%	128 $91,000
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $4,763 - $5,788	7 Added 5.98%	124 $101,000
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $5,647 - $6,131	8 Added 7.34%	117 $84,000
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $5,165 - $6,518	9 Added 9.0%	109 $75,000
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $1,096 - $1,477	-2 Reduced 1.96%	100 $59,000
Q1 2022 Aug 23, 2022	BUY	$595.12 - $698.43 $5,951 - $6,984	10 Added 10.87%	102 $71,000
Q1 2022 Apr 14, 2022	BUY	$595.12 - $698.43 $8,926 - $10,476	15 Added 19.48%	92 $64,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $17,934 - $22,142	33 Added 75.0%	77 $49,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $4,592 - $5,447	8 Added 22.22%	44 $27,000
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $4,255 - $5,026	9 Added 33.33%	36 $20,000
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $1,634 - $1,974	3 Added 12.5%	27 $15,000
Q2 2020 Aug 06, 2020	SELL	$493.32 - $643.92 $986 - $1,287	-2 Reduced 7.69%	24 $15,000
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $5,378 - $7,910	16 Added 160.0%	26 $13,000
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $2,193 - $3,012	-8 Reduced 44.44%	10 $4,000
Q3 2019 Nov 01, 2019	BUY	$273.46 - $318.39 $1,640 - $1,910	6 Added 50.0%	18 $5,000
Q2 2019 Aug 08, 2019	SELL	$299.6 - $414.82 $4,494 - $6,222	-15 Reduced 55.56%	12 $4,000
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $7,441 - $8,791	20 Added 285.71%	27 $11,000
Q2 2018 Aug 09, 2018	BUY	$284.6 - $344.99 $284 - $344	1 Added 16.67%	7 $2,000
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $315 - $393	1 Added 20.0%	6 $2,000
Q4 2017 Feb 06, 2018	SELL	$358.63 - $469.95 $1,075 - $1,409	-3 Reduced 37.5%	5 $2,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $1,294 - $1,512	3 Added 60.0%	8 $4,000
Q2 2017 Aug 09, 2017	BUY	N/A	5	5 $2,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account